General Info
Melissa McCracken, Ph.D., is a scientist with a passion for emerging technologies in cancer therapies. She joined Nextech Invest Ltd. in 2019, a global venture capital firm based in Zurich, Switzerland, focusing on oncology therapeutics. Nextech Invest invests in drug discovery companies in the US and Europe, supporting them through each critical stage of development and growth. Melissa’s previous investments include companies like A2 Biotherapeutics, Autolus, Blueprint Medicines, and Kura Oncology.
Location:
Country: Switzerland
Industries:
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-found
AI Reasoning: Search found profile pages (A2 Biotherapeutics) showing Melissa McCracken affiliated with Nextech Invest and board roles, but no clear recent investment date or press release indicating when last investment occurred. Without a verifiable date of last investment activity, default to not-found.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Melissa McCracken
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI